1. Home
  2. VCEL vs FCNCP Comparison

VCEL vs FCNCP Comparison

Compare VCEL & FCNCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • FCNCP
  • Stock Information
  • Founded
  • VCEL 1989
  • FCNCP N/A
  • Country
  • VCEL United States
  • FCNCP United States
  • Employees
  • VCEL N/A
  • FCNCP 17475
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • FCNCP Major Banks
  • Sector
  • VCEL Health Care
  • FCNCP Finance
  • Exchange
  • VCEL Nasdaq
  • FCNCP Nasdaq
  • Market Cap
  • VCEL 2.1B
  • FCNCP N/A
  • IPO Year
  • VCEL 1997
  • FCNCP N/A
  • Fundamental
  • Price
  • VCEL $30.02
  • FCNCP $21.76
  • Analyst Decision
  • VCEL Strong Buy
  • FCNCP
  • Analyst Count
  • VCEL 6
  • FCNCP 0
  • Target Price
  • VCEL $60.60
  • FCNCP N/A
  • AVG Volume (30 Days)
  • VCEL 811.4K
  • FCNCP N/A
  • Earning Date
  • VCEL 11-06-2025
  • FCNCP N/A
  • Dividend Yield
  • VCEL N/A
  • FCNCP N/A
  • EPS Growth
  • VCEL 2045.40
  • FCNCP N/A
  • EPS
  • VCEL 0.13
  • FCNCP N/A
  • Revenue
  • VCEL $249,119,000.00
  • FCNCP N/A
  • Revenue This Year
  • VCEL $18.35
  • FCNCP N/A
  • Revenue Next Year
  • VCEL $22.47
  • FCNCP N/A
  • P/E Ratio
  • VCEL $224.93
  • FCNCP N/A
  • Revenue Growth
  • VCEL 16.13
  • FCNCP N/A
  • 52 Week Low
  • VCEL $29.94
  • FCNCP N/A
  • 52 Week High
  • VCEL $63.00
  • FCNCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 35.84
  • FCNCP 48.56
  • Support Level
  • VCEL $30.26
  • FCNCP $21.56
  • Resistance Level
  • VCEL $33.25
  • FCNCP $21.94
  • Average True Range (ATR)
  • VCEL 1.67
  • FCNCP 0.29
  • MACD
  • VCEL -0.21
  • FCNCP -0.05
  • Stochastic Oscillator
  • VCEL 1.31
  • FCNCP 47.50

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About FCNCP First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through its extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

Share on Social Networks: